Anti-covid-19 medicines are being approved too easily
And maybe for the wrong reasons
WHAT DO A malaria drug, a Russian vaccine and the blood plasma of people who have recovered from covid-19 have in common? All have been approved for use by governments in response to the coronavirus pandemic, with little or no scientific substance to back those decisions up.
This article appeared in the Science & technology section of the print edition under the headline “Trials and tribulations”
From the August 29th 2020 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Science & technology
Wasps stole genes from viruses
That probably assisted their evolutionary diversification
America’s departure from the WHO would harm everyone
Whether it is a negotiating ploy remains to be seen
Genetic engineering could help rid Australia of toxic cane toads
It is better than freezing them to death
High-tech antidotes for snake bites
Genetic engineering and AI are powering the search for antivenins
Can you breathe stress away?
It won’t hurt to try. But scientists are only beginning to understand the links between the breath and the mind
The Economist’s science and technology internship
We invite applications for the 2025 Richard Casement internship